| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SMARCA5_0003700 | Exon-Exon | chr4:144449021-144456117 | chr4:143527868-143534964 | 467 nt | 0.3747 |
| hsa_SMARCA5_0003800 | Exon-Exon | chr4:144449021-144459864 | chr4:143527868-143538711 | 278 nt | 0.3633 |
| hsa_SMARCA5_0003900 | Exon-Exon | chr4:144449021-144460091 | chr4:143527868-143538938 | 156 nt | 0.3269 |
| hsa_SMARCA5_0004000 | Exon-Exon | chr4:144449021-144465125 | chr4:143527868-143543972 | 120 nt | 0.3667 |
| hsa_SMARCA5_0003600 | Exon-Exon | chr4:144449021-144471257 | chr4:143527868-143550104 | 2292 nt | 0.3879 |
| hsa_SMARCA5_0004100 | Exon-Exon | chr4:144449736-144466736 | chr4:143528583-143545583 | 1440 nt | 0.3965 |
| hsa_SMARCA5_0004300 | Exon-Exon | chr4:144456008-144457670 | chr4:143534855-143536517 | 176 nt | 0.4034 |
| hsa_SMARCA5_0004400 | Exon-Exon | chr4:144456008-144461648 | chr4:143534855-143540495 | 243 nt | 0.4156 |
| hsa_SMARCA5_0004600 | Exon-Exon | chr4:144457736-144461648 | chr4:143536583-143540495 | 504 nt | 0.4107 |
| hsa_SMARCA5_0004900 | Exon-Exon | chr4:144459743-144464810 | chr4:143538590-143543657 | 275 nt | 0.4145 |
A study in mice demonstrated that the circSMARCA5 promotes angiogenesis by sponging SRSF1 mRNA to regulate VEGF-A [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746]. A study in human bloodstains demonstrated that the circSMARCA5 exhibited linear degradation over 120 days, with its relative expression negatively correlated with bloodstain age both indoors (r=0.81) and outdoors (r=0.91), and it was incorporated into a mathematical formula for estimating the time since deposition [Wei et al. DOI:10.1016/j.forsciint.2022.111408]. A separate review noted that in human plasma, the circSMARCA5 is lower in patients with more severe coronary atherosclerosis, with an AUC of 0.589, indicating its potential as a diagnostic biomarker for stable coronary artery disease [Tian et al. DOI:10.3390/molecules26041155].